Boehringer returns to Sino Biopharma in $7.4B deal for preclinical TCEs, ADCs
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
7 trends tracked about this subject — the full history, oldest to newest below.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
GSK anticipates its oncology clinical pipeline will nearly double in 2027 following an aggressive period of dealmaking and strategic acquisitions.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Genmab releases new phase 2 data for its antibody-drug conjugate, prompting claims of superiority over rival treatments.
Merck and Daiichi Sankyo pull their US lung cancer drug application following regulatory pushback.
A new modular in vivo antibody-ADC click chemistry approach aims to reverse drug resistance in tumors, including pancreatic cancer.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.